2003
Chapter 45 Macrophage migration inhibitory factor (MIF)
Arenberg D, Bucala R. Chapter 45 Macrophage migration inhibitory factor (MIF). 2003, II: 1037-xxxiii. DOI: 10.1016/b978-012689663-3/50049-1.Peer-Reviewed Original ResearchMacrophage migration inhibitory factorMigration inhibitory factorRegulation of MIFCritical pro-inflammatory mediatorInhibitory factorPro-inflammatory mediatorsMIF receptorImmune cellsImmunosuppressive propertiesCellular proliferationWidespread expressionMediatorsFuture investigationsCellsInflammationCytokinesGlucocorticoidsPathogenesisSteroidsSecretionActivityImportant roleReceptors
1985
Non‐enzymatic modification of proteins by steroids: Pathological implications for autoimmunity and glucocorticoid toxicity
Bucala R, Cerami A. Non‐enzymatic modification of proteins by steroids: Pathological implications for autoimmunity and glucocorticoid toxicity. BioEssays 1985, 3: 55-59. PMID: 3842583, DOI: 10.1002/bies.950030204.Peer-Reviewed Original ResearchConceptsOral contraceptive agentsElevated plasma levelsHigh steroid levelsGlucocorticoid toxicityPlasma levelsCovalent addition productsPathological sequelaeContraceptive agentsSteroid levelsCertain steroidsAddition productsSteroidsPathological implicationsRearrangement productsMicrosomal oxidationNon-enzymatic modificationRole of Sex Steroids in Systemic Lupus Erythematosus (SLE)
LAHITA R, BUCALA R, BRADLOW H, FISHMAN J. Role of Sex Steroids in Systemic Lupus Erythematosus (SLE). Protides Of The Biological Fluids 1985, 33: 301-304. DOI: 10.1016/b978-0-08-033215-4.50074-1.Peer-Reviewed Original ResearchSystemic lupus erythematosusPathogenesis of SLESex steroidsHydroxylation of estroneLower plasma androgenActive diseaseLupus erythematosusEstrogen metabolismAlpha-hydroxyestroneOxidation of testosteronePlasma androgensPotent estrogenDiseasePathogenesisSteroidsFemalesMalesMetabolismLow levelsErythematosusPatientsAndrogensEstrogenTestosteroneCell membrane